Medicine & Life Sciences
Leishmania infantum
100%
Leishmaniasis
84%
Canidae
63%
Parasites
59%
Dogs
46%
Leishmania
45%
Visceral Leishmaniasis
40%
Infections
23%
Portugal
18%
Meglumine Antimoniate
16%
Zoonoses
14%
Cutaneous Leishmaniasis
13%
Trifluralin
13%
Theileria annulata
13%
Parasitic Diseases
12%
Neutrophils
12%
Macrophages
12%
T-Lymphocytes
12%
Liver
11%
Cellular Immunity
10%
Plasmodium chabaudi
10%
ursolic acid
9%
Cytokines
9%
Allopurinol
9%
Lymph Nodes
9%
Animals
9%
Innate Immunity
8%
Kupffer Cells
8%
Bone Marrow
7%
Antibodies
7%
In Vitro Techniques
7%
Interleukin-10
7%
Skin
6%
Spleen
6%
Liposomes
6%
Cattle
6%
Antibody Formation
6%
Vaccines
6%
falcipain
6%
miltefosine
5%
Agglutination Tests
5%
Interleukin-4
5%
Babesiosis
5%
African Trypanosomiasis
5%
Gene Expression
5%
Phenotype
5%
Phlebotomus
5%
Hepatocytes
5%
Interleukin-12
5%
Theileria
5%
Agriculture & Biology
Leishmania infantum
74%
leishmaniasis
70%
dogs
55%
parasites
37%
Leishmania
29%
promastigotes
27%
infection
24%
visceral leishmaniasis
24%
amastigotes
22%
allopurinol
15%
Portugal
15%
immune response
14%
T-lymphocytes
13%
macrophages
11%
neutrophils
11%
Kupffer cells
11%
Theileria annulata
10%
lymph nodes
10%
cytokines
10%
antibodies
9%
bone marrow
9%
innate immunity
8%
ursolic acid
8%
Leishmania donovani
8%
interleukin-10
8%
therapeutics
8%
blood
8%
relapse
8%
interleukin-4
7%
drug therapy
7%
Plasmodium chabaudi chabaudi
6%
humoral immunity
6%
hepatocytes
6%
immune system
6%
African trypanosomiasis
6%
pathogenicity
6%
Plasmodium chabaudi
5%
interleukin-12
5%
skin (animal)
5%
cell-mediated immunity
5%
cells
5%
animals
5%
immunophenotyping
5%
mice
5%
cutaneous leishmaniasis
5%
antibody formation
5%
trifluralin
5%
clinical examination
5%